Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MAC-awake of Sevoflurane in End-Stage Renal Disease
ChiCTR-OPC-15007608Phase 4Not yet recruiting
- Sponsor
- The Second Affiliated Hospital of Anhui Medical University
- Start
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of sevoflurane in end-stage kidney disease (ESKD) (2 arms), sponsored by The Second Affiliated Hospital of Anhui Medical University. Primary endpoint: MAC-awake of sevoflurane. Planned start Jan 2016; status: not yet recruiting.
02
Drugs
sevoflurane
03
Conditions
end-stage kidney disease (ESKD)
Beyond the preview
Go deeper on ChiCTR-OPC-15007608.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPC-15007608.